Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Sci. Signal., 3 December 2013
Vol. 6, Issue 304, p. ec291
[DOI: 10.1126/scisignal.2004955]

EDITORS' CHOICE

Pharmacology Snuffing Out Marijuana Inflammation

Jason D. Berndt

Science Signaling, AAAS, Washington, DC 20005, USA

Marijuana (cannabis) is used by many cultures for its medicinal properties; however, chronic use can lead to impaired cognition and memory. The active ingredient in marijuana {Delta}9-tetrahydrocannabinol (THC) binds to the cannabinoid receptors CB1R and CB2R to activate G protein–coupled signaling. Activation of CBRs by the endogenous cannabinoid 2-AG inhibits the proinflammatory enzyme cyclooxygenase-2 (COX-2), which normally promotes production of prostanoids, including prostaglandin-E2 (PGE2). Chen et al. found that, unlike 2-AG, acute administration of THC increased the abundance of COX-2 and PGE2 in the hippocampus of mice. The ability of THC to increase COX-2 required CB1R, and the ability of THC to increase PGE2 required COX-2 activity. The G protein inhibitor, pertussis toxin, a peptide inhibitor of the G protein subunits Gβ and G{gamma}, or short-hairpin RNAs targeting Gβ1 and G{gamma}2, suppressed the ability of THC to increase COX-2 and promote activation of several other downstream targets. Short-hairpin RNAs targeting Gαi1 inhibited the ability of 2-AG to reduce COX-2 activity induced by inflammation, but those targeting Gαi1, Gαi2, or Gαi3 had no effect on THC-mediated increases in COX-2 abundance. Pharmacologic or genetic inhibition of COX-2 abrogated defects in hippocampal long-term potentiation, dendritic spine and synapse formation, and glutamate homeostasis, as well as deficits in spatial memory, fear-conditioned responses, and locomotion in mice repeatedly dosed with THC. In a mouse model of Alzheimer’s disease, repeated THC treatment reduced amyloidosis and neuronal degeneration, an effect that was unchanged by the COX-2 inhibitor celecoxib, suggesting that therapies combining THC and COX-2 inhibitors may have improved clinical utility over marijuana use alone.

R. Chen, J. Zhang, N. Fan, Z.-Q. Teng, Y. Wu, H. Yang, Y.-P. Tang, H. Sun, Y. Song, C. Chen, {Delta}9-THC-caused synaptic and memory impairments are mediated through COX-2 signaling. Cell 155, 1154–1165 (2013). [PubMed]

Citation: J. D. Berndt, Snuffing Out Marijuana Inflammation. Sci. Signal. 6, ec291 (2013).



To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882